Bionano Genomics, Inc. entered into a securities purchase agreement for the sale of shares and convertible debentures, receiving net proceeds of approximately $17.9 million and using $17.6 million to redeem a previous note.
AI Assistant
BIONANO GENOMICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.